The UCLA Division of Gynecologic Oncology provides individualized care in a supportive environment with the latest technological advances. Patients undergo treatments with our multidisciplinary team including gynecologic oncologists, radiation oncologists, medical oncologists, genetic counselors, and symptom management experts.
We care for women with gynecologic cancer and those at high risk for gynecologic cancer based on family history.
200 Medical Plaza, Suite 220
Los Angeles, CA 90095
New Patient Fax: 310-794-9110
Hours: Monday through Friday, 8 am to 5 pm
1250 La Venta Drive, Suite 105
Westlake Village, CA 91361
New Patient Fax: 805-557-7181
West Hills Location
7345 Medical Center Drive
West Hills, CA 91307
Santa Monica Location
1245 16th Street., Suite 202
Santa Monica, CA, 90404
-Radiology reports and CDs
-Pathology reports with slides
In addition to our main location in Westwood, we have outreach clinics in Santa Monica, Westlake, and West Hills to better serve patients in these areas including the San Fernando Valley.
We understand that each woman has unique medical and emotional needs.
In order to best address these needs, we work closely with highly qualified experts who specialize in a variety of medical fields. Weekly meetings are held to discuss the best management for patients who need treatment. At these meetings, the gynecologic oncologists are joined by specialists in the fields of medical oncology, radiation oncology, pathology, clinical trials, nursing and social services.
We work together to evaluate each patient’s situation and to customize a treatment plan that is in the best interests of each individual patient. This cooperative team approach has contributed to UCLA being named Best Hospital in West by U.S. News and World Report for 19 years and for the UCLA Jonsson Comprehensive Cancer Center to be recognized as Best Cancer Center in California for 7 consecutive years.
One research goal at the G.O. Discovery Lab is to improve the way we treat patients with gynecologic cancers. As part of this goal, we are looking for effective and better tolerated therapies for endometrial cancer.
Endometrial cancer (a form of uterine cancer) is the most common gynecologic cancer in the U.S. It originates from the endometrium, a specialized and hormonally sensitive cell layer that lines the inside of the uterus. When the endometrium becomes abnormal the cells over grow inside the uterus leading to formation of hyperplasia (crowded abnormal cells) and ultimately cancer. While endometrial cancer is often curable if detected in early stages, the side-effects of current therapies (surgery, radiation and chemotherapy) can have life-long debilitating effects. These standard treatments may be ineffective in patients with later stages of endometrial cancer, where the disease has returned or spread to other organs.
Currently, patients in their child-bearing years who would prefer to preserve their uterus often have no choice but to undergo a hysterectomy, destroying their fertility.